Studies have shown that after CAG treatment in PD mice, there was a significant reduction of alpha-synuclein in the hippocampus and cortex, and a significant improvement in the mice’s motor function, suggesting that TERT can alleviate the symptoms of PD by inhibiting the aggregation of alpha-synuclein (74). Here, SNCA is linked to Parkinson disease.